Galectin Therapeutics Inc.Galectin Therapeutics Inc.Galectin Therapeutics Inc.

Galectin Therapeutics Inc.

No trades
See on Supercharts
Market capitalization
‪209.23 M‬USD
−0.75USD
‪−41.07 M‬USD
‪42.38 M‬
Beta (1Y)
−0.55

About Galectin Therapeutics Inc.

CEO
Joel Lewis
Headquarters
Norcross
Employees (FY)
14
Founded
2000
ISIN
US3632252025
FIGI
BBG000BK6FP5
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GALT is 3.31 USD — it has decreased by 2.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Galectin Therapeutics Inc. stocks are traded under the ticker GALT.
Galectin Therapeutics Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
GALT stock is 5.08% volatile and has beta coefficient of −0.55. Check out the list of the most volatile stocks — is Galectin Therapeutics Inc. there?
One year price forecast for Galectin Therapeutics Inc. has a max estimate of 11.00 USD and a min estimate of 11.00 USD.
GALT earnings for the last quarter are −0.24 USD whereas the estimation was −0.10 USD which accounts for −140.00% surprise. Estimated earnings for the next quarter are −0.10 USD. See more details about Galectin Therapeutics Inc. earnings.
Yes, you can track Galectin Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
GALT stock has fallen by 13.48% compared to the previous week, the month change is a 52.30% rise, over the last year Galectin Therapeutics Inc. has showed a 67.77% increase.
GALT net income for the last quarter is ‪−10.00 M‬ USD, while the quarter before that showed ‪−10.43 M‬ USD of net income which accounts for 4.13% change. Track more Galectin Therapeutics Inc. financial stats to get the full picture.
Today Galectin Therapeutics Inc. has the market capitalization of ‪209.24 M‬, it has increased by 49.00% over the last week.
No, GALT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GALT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Galectin Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
GALT reached its all-time high on Sep 12, 2003 with the price of 38.28 USD, and its all-time low was 0.30 USD and was reached on Jan 12, 2009.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 14.00 employees. See our rating of the largest employees — is Galectin Therapeutics Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Galectin Therapeutics Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Galectin Therapeutics Inc. stock shows the buy signal. See more of Galectin Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Galectin Therapeutics Inc. future price: according to them, GALT price has a max estimate of 11.00 USD and a min estimate of 11.00 USD. Read a more detailed Galectin Therapeutics Inc. forecast: see what analysts think of Galectin Therapeutics Inc. and suggest that you do with its stocks.